RUNX2 and melanoma: It is important to note that the CXCL12/CXCR4 axis activates the AKT and ERK cell signalling pathways [41], and we have recently demonstrated that a reciprocal activation between the RUNX2 and AKT/ERK pathways occurs in melanoma [4].